AeriSeal System: Clinical Trials

7 trials of AeriSeal System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 recruiting, 1 unknown. 3 Phase 2, 3 Phase 3, 2 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 33Terminated 2, Completed 1
Not applicable2Completed 1, Recruiting 1
Phase 11Completed 1
Phase 41Unknown 1

Follow AeriSeal System: new trials by email Literature Review of AeriSeal System trials Research Report on AeriSeal System

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
AeriSeal System - Emphysema, Pulmonary, Emphysema or COPD
Not applicableRecruitingPulmonx Corporation2002024-02-222026-09-17
Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System
AeriSeal System - Emphysema
Not applicableCompletedPulmonx Corporation142016-11-012019-05-31
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Treatment plus Optimal Medical Therapy, Optimal Medical Therapy - Pulmonary Emphysema
Phase 3TerminatedAeris Therapeutics3002012-06-012013-11-14
AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
AeriSeal System - Pulmonary Emphysema, COPD
Phase 4UnknownLudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology102011-04-012011-10-27
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease(COPD)
Phase 2 / Phase 3TerminatedAeris Therapeutics182011-03-012013-11-14
AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, COPD
Phase 2 / Phase 3CompletedAeris Therapeutics202010-08-012011-10-21
AeriSeal System for Lung Volume Reduction
AeriSeal System - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 / Phase 2CompletedAeris Therapeutics552009-11-012013-06-26

Conditions studied

Emphysema (7)  ·  Pulmonary Disease, Chronic Obstructive (6)  ·  Pulmonary Emphysema (6)  ·  Lung Diseases (5)  ·  Respiratory Aspiration (4)  ·  Respiratory Tract Diseases (4)  ·  Pathologic Processes (3)

Sponsors

Aeris Therapeutics (4)  ·  Pulmonx Corporation (2)  ·  LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology (1)

Countries

Austria (4)  ·  Israel (4)  ·  France (3)  ·  Germany (3)  ·  Netherlands (3)  ·  Italy (2)  ·  Spain (2)  ·  United States (2)  ·  Australia (1)  ·  Denmark (1)  ·  Greece (1)  ·  United Kingdom (1)

Top investigators

Narinder Shargill, PhD (2)  ·  Arschang Valipour, MD, FCCP (1)

Results publications

PMID 22374920, PMID 25837041